SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
14.50
0.00 (0.00%)
Oct 10, 2025, 4:39 PM GMT+1

SkinBioTherapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Oct '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2016 - 2019
3818223210022
Upgrade
Market Cap Growth
52.61%-17.78%-31.83%-68.11%353.88%-14.37%
Upgrade
Enterprise Value
371521299419
Upgrade
Last Close Price
0.140.090.130.200.640.17
Upgrade
PS Ratio
14.0114.72163.89424.66--
Upgrade
PB Ratio
8.365.9910.8512.8319.098.90
Upgrade
P/TBV Ratio
158.87-16.7217.1621.2410.72
Upgrade
EV/Sales Ratio
13.9312.45158.92384.18--
Upgrade
Debt / Equity Ratio
0.230.280.050.050.03-
Upgrade
Asset Turnover
0.470.310.050.02--
Upgrade
Inventory Turnover
2.712.080.60---
Upgrade
Quick Ratio
1.210.633.054.1911.917.55
Upgrade
Current Ratio
1.790.933.254.5812.507.70
Upgrade
Return on Equity (ROE)
-63.28%-115.85%-126.85%-72.62%-37.31%-47.80%
Upgrade
Return on Assets (ROA)
-27.75%-46.50%-66.02%-42.26%-22.00%-30.21%
Upgrade
Return on Capital (ROIC)
-34.47%-61.71%-79.79%-46.84%-23.93%-32.27%
Upgrade
Earnings Yield
-6.86%-16.16%-13.10%-8.80%-1.44%-6.84%
Upgrade
FCF Yield
--15.40%-12.64%-8.42%-1.56%-4.07%
Upgrade
Buyback Yield / Dilution
-19.79%-13.10%-5.06%-6.87%-14.53%-4.95%
Upgrade
Updated Dec 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.